Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
1241
Raw data.
Published 2025“…Male KO mice also displayed a significant decrease in rearing activity and blood pressure. …”
-
1242
S1 Graphical abstract -
Published 2025“…</p><p>Conclusions</p><p>Our analysis showed a significant decrease in mortality from paroxysmal tachycardia since 1999, although there has been a slight increase in recent years. …”
-
1243
-
1244
DataSheet1_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
-
1245
DataSheet3_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
-
1246
DataSheet2_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
-
1247
DataSheet4_Significant nocturnal wakefulness after sleep onset in metabolic dysfunction–associated steatotic liver disease.PDF
Published 2024“…Further, data from sleep questionnaires proved sleep-wake disruption in patients with MASLD. We objectively assessed sleep-wake rhythms in patients with biopsy-proven MASLD (n = 35) and healthy controls (HC, n = 16) using actigraphy 24/7 for 4 weeks. …”
-
1248
-
1249
-
1250
-
1251
-
1252
-
1253
-
1254
-
1255
-
1256
-
1257
Renal outcomes of both treatment groups.
Published 2025“…Participants in the multifactorial group achieved a significant mean difference in low-density lipoprotein cholesterol levels (mean difference = −0.14, 95% CI: −0.27–0.001, P < 0.03), and significant adjusted mean difference of eGFR levels difference (3.93 mL/min/1.73 m<sup>2</sup>, 95% CI: 1.27–6.58, P < 0.01) at study completion compared to those in the control group. …”
-
1258
Manuscript data.
Published 2025“…Moreover, the total tomato fruit yield also decreased significantly at salinity-3 compared to salinity-1.…”
-
1259
Sequence of <i>DpAP2</i> promoter.
Published 2024“…It was speculated that MeJA significantly decreased expression of <i>DpAP2</i> gene, then the decreasing <i>DpAP2</i> expression significantly inhibited expression of some key enzyme genes such as <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> in carotenoid biosynthesis pathway. …”
-
1260
Predicted <i>cis</i>-acting elements in <i>DpAP2</i> promoter.
Published 2024“…It was speculated that MeJA significantly decreased expression of <i>DpAP2</i> gene, then the decreasing <i>DpAP2</i> expression significantly inhibited expression of some key enzyme genes such as <i>PSY</i>, <i>PDS</i> and <i>GGPS</i> in carotenoid biosynthesis pathway. …”